Pain Therapeutics announces $11.3 million registered direct offering priced at-the-market
Pain Therapeutics announced that it has entered into definitive agreements with several institutional investors for the purchase of 8,860,778 shares of its common stock, at a purchase price per share of $1.15, for gross proceeds of $10.19 million, in a registered direct offering. August 16, 2018